Perfil
Jennifer Creel worked as Vice President-Global Finance & Business Planning at Celgene Corp.
from 2008 to 2020.
She then worked as Chief Financial Officer at ADC Therapeutics SA from 2020 to 2022.
Ms. Creel received an undergraduate degree from The College of William & Mary and an MBA from the University of Virginia Darden School of Business.
Antiguos cargos conocidos de Jennifer Creel.
Empresas | Cargo | Fin |
---|---|---|
ADC THERAPEUTICS SA | Director of Finance/CFO | 19/12/2022 |
CELGENE | Corporate Officer/Principal | 01/01/2020 |
Formación de Jennifer Creel.
The College of William & Mary | Undergraduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ADC THERAPEUTICS SA | Health Technology |
Empresas privadas | 1 |
---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Creel